Impact Factor
3.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.73
1,813 total citations
h5-index
40
h5 depth signal
Cited share
68.0%
500 of 735
Total citations
1,813
Citation footprint
Metric signal
2.67
External metric anchor
Self-citation
1.1%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
1,931
Japan
728
South Korea
221
United States
99
Italy
97
Citing Fields of Research
Lung Cancer
2,201
Immunology
550
Oncology
416
Noncoding RNA
247
Cancer & Development
188
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,953
Articles tracked across the journal lifetime
Indexed publication set
735
500 cited publications
Last 12 months
223
18.6 publications/month
Open access share
100.0%
223 OA publications in the last year
Leading citing country
China
1,931 citing publications
Leading citing field
Lung Cancer
2,201 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan. 2016-
v6n1, Jan. 2015-
Active Coverage
Research Focus & Classification
Indexed Subjects
Lung Cancer
Issuing & Sponsoring Bodies
Contributor
Zhongguo kang ai xie hui. Fei ai zhuan ye wei yuan hui
Contributor
International Chinese Society of Thoracic Surgery
Contributor
Tianjin Shi fei ai yan jiu suo
Broad Categories
Neoplasms
Pulmonary Medicine
Lung Cancer
MeSH Descriptors
Thoracic Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/1759-7714.70404
Open DOI
Exhaled Breath Analysis for Lung Cancer Detection: From VOCs Signatures to EBC ‐Based Liquid Biopsy and Clinical Translation
Lung cancer remains the leading cause of cancer‐related mortality globally. Although low‐dose computed tomography (LDCT) is the current standard for early screening, its high false‐positive rates and cumulative radiation exposure create ...
02
DOI 10.1111/1759-7714.70361
Open DOI
KRAS G12S Positive Non‐Small Cell Lung Cancer Mimicking KRAS G12C Positivity on the AmoyDx PCR Panel: A Case Report
A false‐positive KRAS G12C on a multi‐PCR assay using the amplification refractory mutation system can potentially occur in cases harboring certain multi‐nucleotide variants other than KRAS G12C. A 62‐year‐old man with a large left upper...
03
DOI 10.1111/1759-7714.70401
Open DOI
Nodule Dye‐Localization Using Interventional Fluoroscopy for Image‐Guided Sublobar Lung Resection
Background: Precise localization is critical for sublobar resection of small pulmonary nodules. We evaluated the safety, technical efficiency, and clinical outcomes of preoperative percutaneous dye‐localization using a cone‐beam computed...
04
DOI 10.1111/1759-7714.70402
Open DOI
Efficacy and Safety of Trilaciclib for the Prevention of Chemotherapy‐Induced Myelosuppression in Patients With Solid Tumors: A Systematic Review and Meta‐Analysis
Trilaciclib, a cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor administered before chemotherapy, reduces chemotherapy‐induced myelosuppression (CIM) in extensive‐stage small cell lung cancer (ES‐SCLC), but its efficacy across solid tu...
05
DOI 10.1111/1759-7714.70399
Open DOI
Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS ‐Lung 003 Study, Branch Number 28
Background: Immune checkpoint inhibitors (ICIs) improve the prognosis of patients with previously treated non‐small cell lung cancer (NSCLC). However, the efficacy and safety of ICIs for patients with NSCLC complicated with interstitial ...
06
DOI 10.1111/1759-7714.70400
Open DOI
Clinicopathological Features of DLL3 Expression and T‐Cell Infiltration in LCNEC : Insights From Pathology and Clinical Response to Tarlatamab
Background: Large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive lung neuroendocrine neoplasm with poor prognosis. Recently, DLL3‐targeted bispecific T‐cell engagers (BiTEs) have shown promising efficacy in small cell lun...
07
DOI 10.1111/1759-7714.70238
Open DOI
Issue Information
08
DOI 10.1111/1759-7714.70392
Open DOI
Chronic Cigarette Smoke Extract Exposure Promotes Genomic and Phenotypic Reprogramming in Lung Cancer Cells
Background: Cigarette smoke contains numerous toxic compounds that can induce oxidative stress and DNA damage. While smoking is a well‐established driver of lung cancer initiation, the biological consequences of continued exposure after ...
09
DOI 10.1111/1759-7714.70394
Open DOI
RETRACTION : Novel Circular RNA Hsa_circ_0036683 Suppresses Proliferation and Migration by Mediating the MiR ‐4664‐3p/ CDK2AP2 Axis in Non‐Small Cell Lung Cancer
RETRACTION : R. Liu , H. Zhang , J. Xin , S.‐Y. Xie , F. Jiao , Y.‐J. Li , M.‐Y. Chu , J. Qiu and Y.‐F. Yan , “,” Thoracic Cancer 15 , no. ( 2024 ): 1929 ‐ 1945 , https://doi.org/10.1111/1759‐7714.15396 . The above article, published onl...
10
DOI 10.1111/1759-7714.70237
Open DOI
Issue Information
Bibliographical & Catalog Notes
Print issues ceased with v. 5, no. 6 (2014).
Also issued online.